Wells Fargo & Company Relay Therapeutics, Inc. Transaction History

Wells Fargo & Company

$434 Billion
Q3 2024

A detailed history of Wells Fargo & Company transactions in Relay Therapeutics, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 130,467 shares of RLAY stock, worth $619,718. This represents 0.0% of its overall portfolio holdings.

Number of Shares

130,467

Previous 43,805 197.84%

Holding current value

$619,718

Previous $285,000 223.86%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$6.23 - $9.51 $539,904 - $824,155	86,662 Added 197.84%	130,467 $923,000
Q2 2024 Aug 13, 2024	BUY	$5.9 - $8.02 $60,616 - $82,397	10,274 Added 30.64%	43,805 $285,000
Q1 2024 May 10, 2024	BUY	$7.5 - $12.07 $42,615 - $68,581	5,682 Added 20.4%	33,531 $278,000
Q4 2023 Feb 09, 2024	SELL	$6.01 - $11.48 $383,083 - $731,746	-63,741 Reduced 69.59%	27,849 $306,000
Q3 2023 Nov 13, 2023	SELL	$8.24 - $12.97 $409,124 - $643,973	-49,651 Reduced 35.15%	91,590 $770,000
Q2 2023 Aug 15, 2023	BUY	$9.99 - $18.27 $514,644 - $941,197	51,516 Added 57.42%	141,241 $1.77 Million
Q1 2023 May 12, 2023	BUY	$15.0 - $22.76 $1.33 Million - $2.02 Million	88,819 Added 9803.42%	89,725 $1.48 Million
Q4 2022 Feb 13, 2023	SELL	$14.16 - $24.02 $24,454 - $41,482	-1,727 Reduced 65.59%	906 $13,000
Q3 2022 Nov 14, 2022	SELL	$18.07 - $31.37 $13,516 - $23,464	-748 Reduced 22.12%	2,633 $59,000
Q2 2022 Aug 12, 2022	SELL	$13.31 - $34.88 $275,690 - $722,469	-20,713 Reduced 85.97%	3,381 $56,000
Q1 2022 May 16, 2022	SELL	$20.26 - $32.36 $460,428 - $735,413	-22,726 Reduced 48.54%	24,094 $721,000
Q4 2021 Feb 14, 2022	SELL	$26.0 - $37.03 $94,796 - $135,011	-3,646 Reduced 7.22%	46,820 $1.44 Million
Q3 2021 Nov 15, 2021	BUY	$29.75 - $37.99 $591,043 - $754,747	19,867 Added 64.93%	50,466 $1.59 Million
Q2 2021 Aug 16, 2021	BUY	$27.5 - $38.19 $571,422 - $793,550	20,779 Added 211.6%	30,599 $1.12 Million
Q1 2021 May 13, 2021	SELL	$32.52 - $61.53 $435,312 - $823,640	-13,386 Reduced 57.68%	9,820 $340,000
Q4 2020 Feb 09, 2021	SELL	$35.51 - $54.03 $348,353 - $530,034	-9,810 Reduced 29.71%	23,206 $964,000
Q3 2020 Nov 05, 2020	BUY	$32.81 - $45.1 $1.08 Million - $1.49 Million	33,016 New	33,016 $1.41 Million

Others Institutions Holding RLAY

# of Institutions

204

Shares Held

156M

Call Options Held

207K

Put Options Held

40K

View Full List

About Relay Therapeutics, Inc.

Ticker RLAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 120,219,000
Market Cap $571M
Description
Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...

More about RLAY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Relay Therapeutics, Inc. Transaction History